Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$535M |
| 2 |
Meta Platforms (Facebook)
META
|
+$388M |
| 3 |
SLB Ltd
SLB
|
+$348M |
| 4 |
Visa
V
|
+$230M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$350M |
| 2 |
Chevron
CVX
|
+$349M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$337M |
| 4 |
Dell
DELL
|
+$332M |
| 5 |
SODA
SodaStream International Ltd
SODA
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 13.21% |
| 3 | Financials | 10.74% |
| 4 | Real Estate | 9.97% |
| 5 | Utilities | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNCA
3276
DELISTED
Genocea Biosciences, Inc.
GNCA
| $61K | ﹤0.01% |
26,570
+1,724
| +7% | +$8.58K |
|
|
CTEK
3277
DELISTED
CynergisTek, Inc.
CTEK
| $60K | ﹤0.01% |
+12,742
| New | +$55.3K |
|
3278
NextDecade
NEXT
$1.68B
| $59K | ﹤0.01% |
+11,000
| New | +$55.5K |
|
|
TMBR
3279
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $59K | ﹤0.01% |
+37
| New | +$87.7K |
|
|
TTNP
3280
DELISTED
Titan Pharmaceuticals
TTNP
| $58K | ﹤0.01% |
72
-124
| -63% | -$139K |
|
3281
Xcel Brands
XELB
$7.51M
| $58K | ﹤0.01% |
+5,130
| New | +$99.3K |
|
|
DYNT
3282
DELISTED
Dynatronics Corp
DYNT
| $58K | ﹤0.01% |
4,260
+140
| +3% | +$1.91K |
|
|
AGEN
3283
Agenus
AGEN
$276M
| $56K | ﹤0.01% |
+1,203
| New | +$50.2K |
|
3284
Summit Therapeutics
SMMT
$10.2B
| $56K | ﹤0.01% |
49,100
+10,400
| +27% | +$16.2K |
|
3285
Research Frontiers
REFR
$13.6M
| $55K | ﹤0.01% |
35,104
+2,804
| +9% | +$4.08K |
|
3286
Plus Therapeutics
PSTV
$25M
| $54K | ﹤0.01% |
10
-1
| -9% | -$6.58K |
|
|
TAT
3287
DELISTED
TransAtlantic Petroleum LTD.
TAT
| $54K | ﹤0.01% |
52,331
-75,400
| -59% | -$90K |
|
3288
IT Tech Packaging
ITP
$2.86M
| $49K | ﹤0.01% |
7,780
-720
| -8% | -$5.51K |
|
|
NHLD
3289
DELISTED
National Holdings Corporation
NHLD
| $47K | ﹤0.01% |
17,400
+2,680
| +18% | +$8.32K |
|
3290
American Shared Hospital Services
AMS
$10.1M
| $46K | ﹤0.01% |
19,181
-10,719
| -36% | -$31.2K |
|
|
SELF
3291
Global Self Storage
SELF
$58.5M
| $46K | ﹤0.01% |
11,700
-25,400
| -68% | -$102K |
|
3292
Edesa Biotech
EDSA
$51.6M
| $45K | ﹤0.01% |
1,177
+708
| +151% | +$33.1K |
|
|
GMO
3293
DELISTED
General Moly, Inc.
GMO
| $45K | ﹤0.01% |
201,041
-34,310
| -15% | -$7.81K |
|
|
GNMX
3294
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $45K | ﹤0.01% |
64,877
+36,107
| +126% | +$40.3K |
|
3295
Axsome Therapeutics
AXSM
$11.7B
| $43K | ﹤0.01% |
+15,110
| New | +$49.7K |
|
3296
Moleculin Biotech
MBRX
$9.61M
| $43K | ﹤0.01% |
+18
| New | +$51.7K |
|
|
ENSV
3297
DELISTED
Enservco Corp.
ENSV
| $43K | ﹤0.01% |
7,802
-10,478
| -57% | -$97.1K |
|
|
OHGI
3298
DELISTED
One Horizon Group, Inc.
OHGI
| $43K | ﹤0.01% |
+477,100
| New | +$86K |
|
3299
NexGen Energy
NXE
$5.91B
| $40K | ﹤0.01% |
+22,700
| New | +$46.5K |
|
3300
Yunhong Green CTI Ltd
YHGJ
$7.75M
| $39K | ﹤0.01% |
1,260
+30
| +2% | +$1.03K |
|
Similar funds
Renaissance Technologies's Q4 2018 Portfolio in Review
As of Q4 2018, Renaissance Technologies held 3,847 positions worth $91.3B, down 6.1% from $97.3B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies deployed $8.84B of net new capital in Q4 2018, opening 522 new positions and adding to 1,588 existing holdings. Its largest new stake was Apple: 11,041,936 shares worth $435M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Dell, an estimated $332M trimmed.
- Renaissance Technologies's largest Q4 2018 buy was Apple: 11,041,936 shares worth $435M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2018, an estimated $388M increase.
- Renaissance Technologies's biggest Q4 2018 reduction was Dell, cutting an estimated $332M.
- Renaissance Technologies fully exited Danaher in Q4 2018, selling an estimated $350M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.3B portfolio in Q4 2018.
- Renaissance Technologies opened 522 new positions and closed 504 in Q4 2018.
- Renaissance Technologies's portfolio value fell 6.1% quarter-over-quarter to $91.3B.
Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.